Guangdong Province Key Laboratory of Animal Nutritional Regulation, National Engineering Research Center for Breeding Swine Industry, College of Animal Science, South China Agricultural University, Guangzhou, 510640, China.
Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, 1100 Bates Ave., Room 8070, Houston, TX 77030, USA.
Cell Rep. 2017 Sep 5;20(10):2455-2467. doi: 10.1016/j.celrep.2017.08.049.
Although the widely used anticoagulant drug heparin has been shown to have many other biological functions independent of its anticoagulant role, its effects on energy homeostasis are unknown. Here, we demonstrate that heparin level is negatively associated with nutritional states and that heparin treatment increases food intake and body weight gain. By using electrophysiological, pharmacological, molecular biological, and chemogenetic approaches, we provide evidence that heparin increases food intake by stimulating AgRP neurons and increasing AgRP release. Our results support a model whereby heparin competes with insulin for insulin receptor binding on AgRP neurons, and by doing so it inhibits FoxO1 activity to promote AgRP release and feeding. Heparin may be a potential drug target for food intake regulation and body weight control.
尽管广泛使用的抗凝药物肝素已被证明具有许多与其抗凝作用无关的其他生物学功能,但它对能量平衡的影响尚不清楚。在这里,我们证明了肝素水平与营养状态呈负相关,肝素治疗会增加食物摄入和体重增加。通过使用电生理学、药理学、分子生物学和化学遗传学方法,我们提供了证据表明肝素通过刺激 AgRP 神经元和增加 AgRP 释放来增加食物摄入。我们的结果支持这样一种模式,即肝素与胰岛素竞争 AgRP 神经元上的胰岛素受体结合,通过这种方式抑制 FoxO1 活性以促进 AgRP 释放和进食。肝素可能是调节食物摄入和控制体重的潜在药物靶点。